Arancha Cebrián Aranda

Has grant

Instituto de Investigación Sanitaria La Fe

Spain

Research Interests

Explore related searches

Professors in Spain Professors in Immunology Immunology professors in Spain

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Recent Grants

Grant: Close

RATIONALE FOR NEW COMBINED TARGETED THERAPY IN METASTATIC COLORECTAL CANCER BASED ON AURORA KINASE AND HIPPO PATHWAY

Open Date: 2020-01-01

Close Date: 2022-12-01

Grant: Close

Caracterización y modulación de los mecanismos de resistencia a los inhibidores de PLK1 en CCR

Open Date: 2017-01-01

Close Date: 2019-12-01

Articles (9)

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2022

Year:

2022

Year:

2021

Year:

Professor of Research

Consejo Superior de Investigaciones Cientificas

SPAIN

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Arancha Cebrián Aranda

Research Interests

Explore related searches

Contact this professor

Recent Grants

Articles (9)

Reply to Dr. Rafael Rosell: Shedding some light on the unresolved issue of YAP1 Ser397 phosphorylation in cancer

POLQ immunostaining behaves as a prognostic factor for pancreatic carcinoma

Inhibition of the AURKA/YAP1 axis is a promising therapeutic option for overcoming cetuximab resistance in colorectal cancer stem cells

Vitamin-C-dependent downregulation of the citrate metabolism pathway potentiates pancreatic ductal adenocarcinoma growth arrest

Galectin-1, a novel promising target for outcome prediction and treatment in SCLC

Choline Kinase α Inhibitors MN58b and RSM932A Enhances the Antitumor Response to Cisplatin in Lung Tumor Cells

Improving selection of patients with metastatic colorectal cancer to benefit from cetuximab based on KIR genotypes.

Overcoming PLK1 inhibitor resistance by targeting mevalonate pathway to impair AXL-TWIST axis in colorectal cancer.

Targeting Galectin-1 by Aflibercept Strongly Enhances Its Antitumor Effect in Neuroendocrine Carcinomas.

Collaborators (5)

Laura del Puerto Nevado

Rosario Perona

Garcia-Foncillas J

Elia Pérez Aguirre

Juan Carlos Lacal

Make your next move.